CML 0.035 +9.38%. Will churn 31-35 on the lead up to results. Break of 35 could see a decent run higher. One of the few resource drill efforts I'll consider holding some of my trade to results.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
